Prenatal phthalate exposure associated with autistic traits in young boys

Summary: Higher gestational concentrations of phthalate metabolites were associated with an increased risk of autism in boys, but not in girls. Folic acid may help to protect against the effects of phthalate exposure, researchers report.

Source: University of Massachusetts Amherst

Exposure in the womb to phthalates, a group of endocrine-disrupting chemicals present in cosmetics and other common household products, was associated with autistic traits in boys, ages 3 and 4, but not in girls, according to a new study led by a University of Massachusetts Amherst environmental epidemiologist.

Fewer of these autistic traits – which are characterized by social behavior, repetitive behaviors and restricted interests, but do not constitute an autism diagnosis – were found among boys whose mothers had taken the recommended dose of supplementary folic acid during their first trimester of pregnancy.

“This is one of the largest cohort studies about phthalates and neurodevelopment,” says lead author Youssef Oulhote, assistant professor of biostatistics and epidemiology at UMass Amherst’s School of Public Health and Health Sciences. “One of the most important findings is how adequate folic acid supplementation in pregnancy may offset the potentially harmful effects of phthalates in regard to autistic traits.”

Published Feb. 19 in the journal Environmental Health Perspectives, the study is the first to find this particular protective effect of folic acid supplements from phthalates. Oulhote adds that folic acid supplementation might also block the effects of other toxic chemicals, as already has been shown for pesticides and air pollutants.

While autism spectrum disorder “undoubtedly” has an underlying genetic basis, the study’s findings strengthen the evidence that prenatal exposure to toxic chemicals contributes to the development of social impairment traits. Autism spectrum disorder affects about four times more males than females. The study examined only one point in the children’s development.

“We do not know if these subtle effects associated with prenatal phthalate exposure will last after the preschool period,” notes child development specialist and study co-author Gina Muckle, professor at Université Laval and Quebec-CHU Research Center in Quebec City, Canada.

Oulhote and colleagues in the U.S. and Canada analyzed data from the Maternal-Infant Research on Environmental Chemicals (MIREC) prospective cohort study, which enrolled 2,001 women during their first trimester of pregnancy from 10 cities in Canada between 2008 and 2011. Oulhote first worked on the MIREC study as a post-doctoral researcher and is still conducting additional analyses on other chemicals. So far, researchers have produced more than 70 papers in peer-reviewed scientific journals from examining MIREC’s data sets.

This shows a pregnant woman
Oulhote adds that folic acid supplementation might also block the effects of other toxic chemicals, as already has been shown for pesticides and air pollutants. Image is in the public domain.

For the current study, researchers measured 11 different phthalate metabolites in the pregnant women’s urine samples taken during their first trimester and recorded the women’s folic acid supplement intake. In follow-up investigation, 601 3- and 4-year-old children of the women underwent neuropsychological assessments, including the Social Responsiveness Scale-II (SRS-2) as a measure of autistic traits and social impairment. SRS-2 is a parent-reported questionnaire that has been found to be valid and reliable method to assess autistic traits in the general population and clinical settings. It correlates well with the assessment tools that physicians use to diagnose autistic spectrum disorder, although its validity in discriminating autism from other behavioral diagnoses deserves more attention, Oulhote says.

Increases in urinary concentrations of phthalate chemicals were associated with increases in SRS scores – but only among children whose mothers did not take an adequate folic acid supplement, 400 mcg daily, during their first trimester.

Oulhote notes that most of the women in the study were white, employed, married or living with a partner, and well-educated. “These are not the higher exposures for certain phthalates you will find in low-income communities,” says Oulhote, explaining that cosmetics and other personal care products free of phthalates tend to be the most expensive and not affordable for low-income communities. Phthalates are also used in certain plastics, food packaging and medical devices.

About this neuroscience research article

Source:
University of Massachusetts Amherst
Media Contacts:
Patty Shillington – University of Massachusetts Amherst
Image Source:
The image is in the public domain.

Original Research: Open access
“Gestational Exposures to Phthalates and Folic Acid, and Autistic Traits in Canadian Children”. Youssef Oulhote, Bruce Lanphear, Joseph M. Braun, Glenys M. Webster, Tye E. Arbuckle, Taylor Etzel, Nadine Forget-Dubois, Jean R. Seguin, Maryse F. Bouchard, Amanda MacFarlane, Emmanuel Ouellet, William Fraser, and Gina Muckle.
Environmental Health Perspectives doi:10.1289/EHP5621.

Abstract

Gestational Exposures to Phthalates and Folic Acid, and Autistic Traits in Canadian Children

Background:
The etiology of autism spectrum disorder is poorly understood. Few studies have investigated the link between endocrine-disrupting chemicals and autistic traits. We examined the relationship between gestational phthalates and autistic traits in 3- to 4-y-old Canadian children. We also investigated potential effect modification by sex and folic acid supplementation.

Methods:
We enrolled 2,001 women>18 years of age during the first trimester of pregnancy between 2008 and 2011 from 10 cities in Canada. At 3–4 years of age, 610 children underwent neuropsychological assessments including the Social Responsiveness Scale–II (SRS-2) as a measure of autistic traits and social impairment. We measured 11 phthalate metabolites in maternal first trimester urine samples and assessed folic acid supplementation from reported intakes. We estimated covariate-adjusted differences in SRS-2 T-scores with a doubling in phthalate concentrations in 510 children with complete data.

Results:
Mean total SRS T-score was 45.3 (SD=6.1). Children with higher gestational exposure to mono-n-butyl (MBP) and mono-3-carboxypropyl (MCPP) concentrations exhibited significantly higher total SRS T-scores, indicating greater overall social impairment, as well as higher scores on subdomains, indicating deficits in social cognition, social communication, social motivation, and restricted interests/repetitive behaviors. A doubling in MBP or MCPP concentrations was associated with 0.6 (95% CI: 0.1, 1.0) and 0.5 (95% CI: 0.1, 0.8) higher total SRS T-scores. Associations were consistently and significantly stronger in boys (βMBP=1.0; 95% CI: 0.4, 1.6; n=252) compared with girls (βMBP=0.1; 95% CI: −0.6, 0.7; n=258) and among children who had lower prenatal folic acid supplementation (<400μg/d) (βMBP=1.3; 95% CI: 0.4, 2.3; n=59) compared with those who had adequate folic acid supplementation (≥400μg/d) (βMBP=0.4; 95% CI: −0.1, 0.8; n=451).

Conclusions:
Higher gestational concentrations of some phthalate metabolites were associated with higher scores of autistic traits as measured by the SRS-2 in boys, but not girls; these small size effects were mitigated by first trimester-of-pregnancy folic acid supplementation.

Feel free to share this ASD News.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive the latest neuroscience headlines and summaries sent to your email daily from NeuroscienceNews.com
We hate spam and only use your email to contact you about newsletters. We do not sell email addresses. You can cancel your subscription any time.